Fluorofenidone Attenuates Diabetic Nephropathy and Kidney Fibrosis in &lt;i&gt;db/db&lt;/i&gt; Mice (Q53225434)

12 May 2018

reason for preferred rank

title

Fluorofenidone Attenuates Diabetic Nephropathy and Kidney Fibrosis in <i>db/db</i> Mice (English)

1 reference

9 December 2024

Fluorofenidone attenuates diabetic nephropathy and kidney fibrosis in db/db mice (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:21847000

9 December 2024

1 reference

Ling Hao Wang

1

1 reference

12 May 2018

Ji Shi Liu

2

1 reference

12 May 2018

Wang Bin Ning

3

1 reference

12 May 2018

Qiong Jing Yuan

4

1 reference

12 May 2018

Fang Fang Zhang

5

1 reference

12 May 2018

Zhang Zhe Peng

6

1 reference

12 May 2018

Miao Miao Lu

7

1 reference

12 May 2018

Ren Na Luo

8

1 reference

12 May 2018

Xiao Fu

9

1 reference

12 May 2018

Gao Yun Hu

10

1 reference

12 May 2018

Zhao He Wang

11

1 reference

12 May 2018

Li Jian Tao

12

1 reference

12 May 2018

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21847000

9 December 2024

publication date

16 August 2011

1 reference

12 May 2018

full work available at URL

https://www.karger.com/Article/Pdf/329419

1 reference

9 December 2024

1 reference

12 May 2018

volume

88

1 reference

12 May 2018

issue

1-2

1 reference

12 May 2018

page(s)

88-99

1 reference

12 May 2018

Progress in diabetes research in China

cites work

1 reference

Is inflammation a common retinal-renal-nerve pathogenic link in diabetes?

21 January 2018

1 reference

Addition of angiotensin receptor blockade or mineralocorticoid antagonism to maximal angiotensin-converting enzyme inhibition in diabetic nephropathy

21 January 2018

1 reference

Extracellular matrix metabolism in diabetic nephropathy

21 January 2018

1 reference

Diabetic nephropathy: mechanisms of renal disease progression

21 January 2018

1 reference

Role of growth factors in diabetic kidney disease

21 January 2018

1 reference

High ambient glucose enhances sensitivity to TGF-beta1 via extracellular signal--regulated kinase and protein kinase Cdelta activities in human mesangial cells.

21 January 2018

1 reference

Glomerular 20-HETE, EETs, and TGF-beta1 in diabetic nephropathy

21 January 2018

1 reference

TGF-beta1-induced epithelial-to-mesenchymal transition and therapeutic intervention in diabetic nephropathy.

21 January 2018

1 reference

Reversibility of established diabetic glomerulopathy by anti-TGF-beta antibodies in db/db mice.

21 January 2018

1 reference

High glucose activates PKC-zeta and NADPH oxidase through autocrine TGF-beta1 signaling in mesangial cells

21 January 2018

1 reference

SMP-534 ameliorates progression of glomerular fibrosis and urinary albumin in diabetic db/db mice

21 January 2018

1 reference

Oral administration of GW788388, an inhibitor of TGF-beta type I and II receptor kinases, decreases renal fibrosis

21 January 2018

1 reference

Isoliquiritigenin entails blockade of TGF-beta1-SMAD signaling for retarding high glucose-induced mesangial matrix accumulation

21 January 2018

1 reference

Potential new therapeutic agents for diabetic kidney disease

21 January 2018

1 reference

Reversal of cardiac and renal fibrosis by pirfenidone and spironolactone in streptozotocin-diabetic rats

21 January 2018

1 reference

The experimental agent pirfenidone reduces pro-fibrotic gene expression in a model of tacrolimus-induced nephrotoxicity

21 January 2018

1 reference

Pirfenidone is renoprotective in diabetic kidney disease

21 January 2018

1 reference

Fluorofenidone attenuates collagen I and transforming growth factor-beta1 expression through a nicotinamide adenine dinucleotide phosphate oxidase-dependent way in NRK-52E cells

21 January 2018

1 reference

Evidence that the diabetes gene encodes the leptin receptor: identification of a mutation in the leptin receptor gene in db/db mice

21 January 2018

1 reference

Diabetic kidney disease in thedb/dbmouse

21 January 2018

1 reference

Estrogen and raloxifene, a selective estrogen receptor modulator, ameliorate renal damage in db/db mice

21 January 2018

1 reference

Galectin-9 inhibits glomerular hypertrophy in db/db diabetic mice via cell-cycle-dependent mechanisms

21 January 2018

1 reference

Long-term renal effects of a neutralizing RAGE antibody in obese type 2 diabetic mice

21 January 2018

1 reference

Peroxisome proliferator activated receptor alpha/gamma dual agonist tesaglitazar attenuates diabetic nephropathy in db/db mice.

21 January 2018

1 reference

Increased glomerular and tubular expression of transforming growth factor-beta1, its type II receptor, and activation of the Smad signaling pathway in the db/db mouse

21 January 2018

1 reference

Determination of AKF-PD in whole blood of rat by HPLC-UV.

21 January 2018

1 reference

High ambient glucose induces angiotensin-independent AT-1 receptor activation, leading to increases in proliferation and extracellular matrix accumulation in MES-13 mesangial cells

21 January 2018

1 reference

Tissue inhibitors of metalloproteinases: evolution, structure and function

21 January 2018

1 reference

Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor-beta antibody in db/db diabetic mice

21 January 2018

1 reference

Renoprotective effect of COMP-angiopoietin-1 in db/db mice with type 2 diabetes

21 January 2018

1 reference

Overview of Glucose Signaling in Mesangial Cells in Diabetic Nephropathy

21 January 2018

1 reference

Pirfenidone Slows Renal Function Decline in Patients with Focal Segmental Glomerulosclerosis

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1159/000329419

1 reference

12 May 2018

1 reference

12 May 2018